green tea
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GBRC .96 ! Global Resource Corp. (Pinksheets:GBRC - News) is a developer of a patent-pending microwave technology and machinery that extracts oil and petroleum products from shale deposits, tar sands, capped oil wells, bituminous coal and processed materials such as tires and plastics as well as dredged soil from harbors and river bottoms. Its process produces significantly greater yields and lower costs than are available using existing technologies. Because the process takes place in an enclosed environment it is emission-free and an efficient and cost-effective tool for cleaning environmental wastes and toxic materials. For more information see: www.globalresourcecorp.com
GBRC Secures $10 Million Financing Commitment
Global Resource Corp. a developer of patent-pending microwave technology and machinery for extracting oil and gas, announced today that it has entered into a $10 million common stock purchase agreement with AGS Capital Group, a New York based institutional investor.
CAVR Announces $2.4 Million Letter of Intent to Acquire ASG, Inc.
CAVR nice buys!
CAVR set to gap , .40 bid
CAVR @ .38 News! CAVU Resources, Inc. Announces Initial Investment on $5 Million Drilling Program
CAVU Resources One, LLC, formed as a drilling and lease Acquisition Company has received the first initial $50,000 investment on its $5 Million Dollar Private Placement. The Limited partnership, CAVU Resources One, LLC has targeted both new wells and leases in proven areas.
IGNT News! Ingen Technologies, Inc., a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the company is an exhibitor at the American Association of Respiratory Care (AARC) 55th international respiratory congress in San Antonio-Texas next month, Further, CEO, Scott Sand, will discuss the AARC exhibition tomorrow November 17, 2009 at 11:34AM eastern standard time on The Money Channel's American Scene Radio with host Steve Crowley.
Id be digging it out in buckets if I had to
DRGZ on the move, profitable company !
DRGZ @ .46 only 900k Outstanding Shares!
Dynamic Response Group, Inc. is a marketing company that develops and distributes personal development and heath services through print catalogs, radio, direct mail, direct response television programming (infomercials) and the Internet.
EVRN should see some major volume today
I have to agree, cant wait to try this product out. My daughter already has me out there looking for it lol
New Record... Activision Blizzard Inc said it sold 4.7 million copies of "Call of Duty: Modern Warfare 2", or $310 million of sales, on its first day, setting a new record for the video game industry.
I think it breaks out today
so over all looks like they are disappointed :/ We got it at Midnight monday seems ok to me. I'm still playen Crysis for now
TRDX Trend Exploration, Inc. News
Announces it is in the process of acquiring the rights to an emergency dental kit product which contains a wide variety of dental treatments for emergency situations (www.dentalkit.com).
ENTB $1 going
EVRN getting mojo
Everock produces a line of all-natural natural gourmet vegetable dips and sandwich spreads marketed under the Nature's Peak brand.
Both VeggieDip and VeggieSpread are 100% all-natural, vegetarian, Kosher and gluten-free, contain no preservatives, artificial ingredients, trans-fats, or sugars. And each product currently comes in six flavors each, including novel delicious flavor combinations. Nature's Peak products may be found in natural food stores, specialty groceries as well as in regional and national grocery chains, restaurants, delis and other food service providers across America.
ENTB News, very low float, Entest BioMedical, Inc. discussed its current therapies in development in the areas of immuno-therapeutic treatment of cancer and Chronic Obstructive Pulmonary Disease (COPD) and their potential to generate significant revenue for the Company.
1. Immuno-therapeutic treatment of cancer – The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. The Company’s initial goal is to treat 2,000 dogs at $3,000 per dog (yielding $6,000,000 in revenue) and believes revenue could begin to be generated within the next 9 months. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.
2. Entest has applied for a contract with the National Cancer Institute (NCI) for the initial development of an immuno-therapeutic cancer drug. This contract, if awarded to Entest, will have a value of $200,000 and will cover Phase I clinical evaluation. If the drug demonstrates reasonable efficacy, NCI may coordinate and fund further development through Phases II and III, with the ultimate goal being commercialization of the drug in partnership with NCI.
3. COPD –There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms. The Company foresees substantial revenue in treating COPD and is currently in discussions with several entities regarding possible joint ventures involving the Company’s developing patent pending treatment.
Entest anticipates funding a significant amount of its research development costs by obtaining grant funding. The Company is in the process of applying for $3 million of federal grant funding for both COPD treatment and immuno-therapeutic treatment of cancer.
About Entest BioMedical Inc.
Entest BioMedical Inc. (OTCBB: ENTB) is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCBB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).
anytime its under 10 I think its a buy buy buy
* Fans line up for midnight release
* Game could be among top-selling of all time
By Gabriel Madway and Robert MacMillan
SAN FRANCISCO/NEW YORK, Nov 10 (Reuters) - Activision Blizzard Inc's (ATVI.O) hugely anticipated "Call of Duty: Modern Warfare 2" video game went on sale early Tuesday morning, welcomed by eager fans who lined up hours in advance of the release.
The first-person shooter game is set to be one of the biggest and fastest-selling titles in history, challenging records set by blockbuster releases from the "Grand Theft Auto" series.
This despite a dicey economic climate that is pinching consumer spending. Video game industry revenue in the United States, the world's largest market, is down 13 percent this year, according to industry tracker NPD.
But Call of Duty arrives amid high expectations and plenty of hype. Activision partnered with retailers including GameStop Corp (GME.N) and Best Buy Co (BBY.N) for more than 10,000 midnight store openings in North America.
At the GameStop store near Union Square in New York City, around 80 mainly young people were lined up Monday night ahead of the launch, some for two hours.
"This is the only game I'm probably going to do this for," said Paola Altamirano, 21, who was waiting in the queue. She said she planned to play Call of Duty against another friend online later that night.
With what Activision called a record level of preorders, there was little doubt about the strong demand for a game.
"Gamers are enthusiastic about picking this stuff up at midnight," said Paul Swiderski, who works at the Union Square Gamestop.
Analysts' sales estimates for the $60 game range from 11-13 million units by the end of 2009. Call of Duty is likely to account for a sizable chunk of Activision's profits in the fourth quarter, analysts say, so there is plenty at stake in the launch.
HARD-CORE AUDIENCE
The audience for the latest Call of Duty -- the sixth instalment in the franchise -- is primarily younger men, the gaming demographic that makes up the core of the estimated $50 billion global industry.
yeh 12.50 plus this week , all the numbers on this new game will be starting to come out after midnight
well Im trying to teach some of the newbies that there is more to the investment world than day trades. This one can be just as exciting fun and the downside risk at $10 and less is very little.
According to reports from insider videogame news site IndustryGamers, the imminent November 10 release of Modern Warfare 2 is causing American retailer GameStop to experience the largest pre-order demand in its history.
GameStop, which operates over 6,200 stores and also owns the EB Games and Micromania brands, said that they received "more pre-orders on this game than all of the games that were sold system-wide globally on the last Call of Duty (World at War) in its first month. This is clearly going to be the biggest entertainment release of our history."
Modern Warfare 2 is released worldwide for Xbox 360, PC, and PlayStation 3 with a multitude of retail options available starting from $59.99 / €59.99 / £54.99. There are also companion versions being made available for Nintendo Wii and Nintendo DS.
My local GameStop has over 200 pre orders for COD MW2, thats twice what Halo was
For the quarter ended September 30, 2009, Activision Blizzard's GAAP net revenues were $703 million, as compared to the company's prior GAAP net revenue outlook of $680 million. On a non-GAAP basis, the company's net revenues were $755 million, as compared with its prior non-GAAP net revenues outlook of $700 million. For the quarter ended September 30, 2009, Activision Blizzard's GAAP earnings per diluted share were $0.01, as compared to its prior GAAP loss per diluted share outlook of $0.03. On a non-GAAP basis, the company's earnings per diluted share were $0.04, as compared to its prior non-GAAP earnings per diluted share outlook of $0.03.
JUNP in top five for trades last ten minutes
IGNT looking great! was ready for a nice bounce!
IGNT Ingen Announces Projections of $10M in Sales for 2010
Ingen Technologies, Inc., a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the CEO, Scott Sand, discussed conservative projections for 2010 on The Money Channel's American Scene Radio with host Steve Crowley this past Tuesday.
NTMI .21 YouTube news, nice pop
NT Media's NeuroTrash.tv Partners up to Launch YouTube Channel for Alternative, Original Entertainment Videos
www.YouTube.com/NeuroTrashTV Hosts Hollywood-Produced Comedy Shorts, Celebrity-Featured Webisode Series and User-Created Videos
NTMI @ .18 NT Media Signs Deal Or No Deal's Leyla Milani to Star in NeuroTrash.tv's Original Series
TCHH moving up on news
Trustcash Holdings Inc. confirms that the Company has decided to expand the methods for purchasing Trustcash to include Euro Debit ("EUDEBIT").
Trustcash will be able to access approximately 100 Million users upon addition of EUDEBIT.
EUDEBIT (European Bank Debit) system is the most widely-used form of payment in Europe for both one-time or recurring payments.
EUDEBIT is the perfect billing solution for European customers with no credit card or those who are reluctant to use them online for purchases and "plastic" of any kind is no longer needed. With a EUDEBIT system, consumers can purchase products or services over the Internet, and the funds are instantly withdrawn from their bank accounts in a safe and efficient manner.
85% of the adults in the European Union have a bank account; this addition offers them a preferred method of doing business with our customers.
JUNP gapping 14%
all set to gap ;)
JUNP Juniper Group announced after the bell that its wholly owned telecommunications subsidiary has been awarded additional contracts stemming from the ongoing work for their customer in the Philadelphia market. New crews are presently being deployed to the Raleigh, Greensboro and Charlotte North Carolina markets.
probably just bottom feeding on a penny play, that shows investors are interested at least. The one year low was like .02 so upside more likely than down imo
looks like I lost an image up there just cant remember what it was lol
I could listen to him all day. isn't he like every ones grandpa
NTMI .22 x .23 only 1.4 mil mrkcap
NTMI starting to move up now,
NT Media Partners with Hollywood Entertainment Producers for Webisode Series "Straight Up With A Twist"